TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $105,775,000 | +74.3% | 3,840,786 | +4.4% | 0.00% | +50.0% |
| Q1 2021 | $60,688,000 | -7.1% | 3,680,272 | +3.8% | 0.00% | 0.0% |
| Q4 2020 | $65,313,000 | +31.9% | 3,543,840 | -2.6% | 0.00% | 0.0% |
| Q3 2020 | $49,533,000 | +3.3% | 3,639,417 | +36.0% | 0.00% | 0.0% |
| Q2 2020 | $47,940,000 | +175.6% | 2,675,252 | +53.3% | 0.00% | +100.0% |
| Q1 2020 | $17,394,000 | +25.4% | 1,744,614 | +2.4% | 0.00% | – |
| Q4 2019 | $13,872,000 | -34.1% | 1,704,210 | -19.7% | 0.00% | -100.0% |
| Q3 2019 | $21,037,000 | +9.2% | 2,122,830 | +39.2% | 0.00% | 0.0% |
| Q2 2019 | $19,259,000 | +123.8% | 1,524,907 | +80.6% | 0.00% | – |
| Q1 2019 | $8,607,000 | +185.9% | 844,577 | +110.4% | 0.00% | – |
| Q4 2018 | $3,011,000 | +4.6% | 401,494 | +39.4% | 0.00% | – |
| Q3 2018 | $2,879,000 | – | 287,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |